Late-Stage C(sp 2)–C(sp 3) Diversification via Nickel Oxidative Addition Complexes

Herein, we describe nickel oxidative addition complexes (Ni-OACs) of drug-like molecules as a platform to rapidly generate lead candidates with enhanced C­(sp 3) fraction. The potential of Ni-OACs to access new chemical space has been assessed not only in C­(sp 2)–C­(sp 3) couplings but also in addi...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the American Chemical Society Vol. 146; no. 31; pp. 21264 - 21270
Main Authors: Odena, Carlota, Santiago, Tomás G., Linares, María Lourdes, Castellanos-Blanco, Nahury, McGuire, Ryan T., Chaves-Arquero, Belén, Alonso, Jose Manuel, Diéguez-Vázquez, Alejandro, Tan, Eric, Alcázar, Jesús, Buijnsters, Peter, Cañellas, Santiago, Martin, Ruben
Format: Journal Article
Language:English
Published: United States American Chemical Society 07-08-2024
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Herein, we describe nickel oxidative addition complexes (Ni-OACs) of drug-like molecules as a platform to rapidly generate lead candidates with enhanced C­(sp 3) fraction. The potential of Ni-OACs to access new chemical space has been assessed not only in C­(sp 2)–C­(sp 3) couplings but also in additional bond formations without recourse to specialized ligands and with improved generality when compared to Ni-catalyzed reactions. The development of an automated diversification process further illustrates the robustness of Ni-OACs, thus offering a new gateway to expedite the design–make–test–analyze (DMTA) cycle in drug discovery.
AbstractList Herein, we describe nickel oxidative addition complexes (Ni-OACs) of drug-like molecules as a platform to rapidly generate lead candidates with enhanced C­(sp 3) fraction. The potential of Ni-OACs to access new chemical space has been assessed not only in C­(sp 2)–C­(sp 3) couplings but also in additional bond formations without recourse to specialized ligands and with improved generality when compared to Ni-catalyzed reactions. The development of an automated diversification process further illustrates the robustness of Ni-OACs, thus offering a new gateway to expedite the design–make–test–analyze (DMTA) cycle in drug discovery.
Herein, we describe nickel oxidative addition complexes (Ni-OACs) of drug-like molecules as a platform to rapidly generate lead candidates with enhanced C(sp3) fraction. The potential of Ni-OACs to access new chemical space has been assessed not only in C(sp2)-C(sp3) couplings but also in additional bond formations without recourse to specialized ligands and with improved generality when compared to Ni-catalyzed reactions. The development of an automated diversification process further illustrates the robustness of Ni-OACs, thus offering a new gateway to expedite the design-make-test-analyze (DMTA) cycle in drug discovery.Herein, we describe nickel oxidative addition complexes (Ni-OACs) of drug-like molecules as a platform to rapidly generate lead candidates with enhanced C(sp3) fraction. The potential of Ni-OACs to access new chemical space has been assessed not only in C(sp2)-C(sp3) couplings but also in additional bond formations without recourse to specialized ligands and with improved generality when compared to Ni-catalyzed reactions. The development of an automated diversification process further illustrates the robustness of Ni-OACs, thus offering a new gateway to expedite the design-make-test-analyze (DMTA) cycle in drug discovery.
Herein, we describe nickel oxidative addition complexes (Ni-OACs) of drug-like molecules as a platform to rapidly generate lead candidates with enhanced C( ) fraction. The potential of Ni-OACs to access new chemical space has been assessed not only in C( )-C( ) couplings but also in additional bond formations without recourse to specialized ligands and with improved generality when compared to Ni-catalyzed reactions. The development of an automated diversification process further illustrates the robustness of Ni-OACs, thus offering a new gateway to expedite the design-make-test-analyze (DMTA) cycle in drug discovery.
Author McGuire, Ryan T.
Alonso, Jose Manuel
Martin, Ruben
Alcázar, Jesús
Buijnsters, Peter
Diéguez-Vázquez, Alejandro
Tan, Eric
Odena, Carlota
Santiago, Tomás G.
Castellanos-Blanco, Nahury
Linares, María Lourdes
Chaves-Arquero, Belén
Cañellas, Santiago
AuthorAffiliation The Barcelona Institute of Science and Technology
Institute of Chemical Research of Catalonia (ICIQ)
Universitat Rovira i Virgili
ICREA, Passeig Lluís Companys
Departament de Química Orgànica
AuthorAffiliation_xml – name: The Barcelona Institute of Science and Technology
– name: Institute of Chemical Research of Catalonia (ICIQ)
– name: Universitat Rovira i Virgili
– name: Departament de Química Orgànica
– name: ICREA, Passeig Lluís Companys
Author_xml – sequence: 1
  givenname: Carlota
  orcidid: 0000-0003-3034-9097
  surname: Odena
  fullname: Odena, Carlota
  organization: Universitat Rovira i Virgili
– sequence: 2
  givenname: Tomás G.
  surname: Santiago
  fullname: Santiago, Tomás G.
  organization: The Barcelona Institute of Science and Technology
– sequence: 3
  givenname: María Lourdes
  surname: Linares
  fullname: Linares, María Lourdes
– sequence: 4
  givenname: Nahury
  surname: Castellanos-Blanco
  fullname: Castellanos-Blanco, Nahury
  organization: The Barcelona Institute of Science and Technology
– sequence: 5
  givenname: Ryan T.
  surname: McGuire
  fullname: McGuire, Ryan T.
  organization: The Barcelona Institute of Science and Technology
– sequence: 6
  givenname: Belén
  surname: Chaves-Arquero
  fullname: Chaves-Arquero, Belén
– sequence: 7
  givenname: Jose Manuel
  surname: Alonso
  fullname: Alonso, Jose Manuel
– sequence: 8
  givenname: Alejandro
  orcidid: 0000-0003-0243-0357
  surname: Diéguez-Vázquez
  fullname: Diéguez-Vázquez, Alejandro
– sequence: 9
  givenname: Eric
  surname: Tan
  fullname: Tan, Eric
– sequence: 10
  givenname: Jesús
  surname: Alcázar
  fullname: Alcázar, Jesús
– sequence: 11
  givenname: Peter
  surname: Buijnsters
  fullname: Buijnsters, Peter
– sequence: 12
  givenname: Santiago
  orcidid: 0000-0002-8700-4615
  surname: Cañellas
  fullname: Cañellas, Santiago
  email: SCanella@its.jnj.com
– sequence: 13
  givenname: Ruben
  orcidid: 0000-0002-2543-0221
  surname: Martin
  fullname: Martin, Ruben
  email: rmartinromo@iciq.es
  organization: ICREA, Passeig Lluís Companys
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39052124$$D View this record in MEDLINE/PubMed
BookMark eNptkLlOw0AQhlcoiBzQUSOXiYTDnva6jMwpRaQg1NZmPYs2-AheOwod78Ab8iQ4B9BQzfXPP5qvjzpFWQBC5wSPCabkaqm0G3ONJcf8CPWIoNgXhAYd1MMYUz-UAeuivnPLtuRUkhPUZREWlFDeQ_OpqsF_qtULePHQrTw6-vr43GVs5F3bNVTOGqtVbcvCW1vlPVr9Cpk329i0ba7Bm6Sp3U3jMl9lsAF3io6NyhycHeIAPd_ezON7fzq7e4gnU19RQmpfBCoKiWQilUZHhi-EMCqQbdeY9jUINcNCq0inkQEluQ6klFpQw0LOQkPZAA33vquqfGvA1UlunYYsUwWUjUtYCyUMKZdb6eVeqqvSuQpMsqpsrqr3hOBkyzHZckwOHFv5xcG5WeSQ_op_wP2d3m4ty6Yq2kf_9_oG6DN8UQ
Cites_doi 10.1246/bcsj.53.139
10.1002/anie.201802656
10.1126/science.1178165
10.1021/ja00234a047
10.1021/jo500507s
10.1556/JFC-D-13-00009
10.1002/anie.201605463
10.1021/jacs.6b01533
10.1002/cctc.202201289
10.1016/0277-5387(95)00141-E
10.1021/acscatal.5b00072
10.1016/j.trechm.2023.10.008
10.1021/acscatal.8b00856
10.1021/acs.orglett.3c01390
10.1038/s41570-017-0025
10.1073/pnas.93.21.11865
10.1021/acs.joc.8b02358
10.1016/S0040-4020(00)00344-6
10.1021/acs.accounts.0c00032
10.1021/acscatal.5b02718
10.1038/nrd.2017.232
10.1038/s41598-019-52085-w
10.1002/adsc.201400243
10.1038/s41557-024-01528-7
10.1021/ja982520o
10.1021/acs.jmedchem.1c01139
10.1039/C9SC06006E
10.1021/ja301769r
10.1126/science.aac6153
10.1016/j.trechm.2023.03.008
10.1016/j.tetlet.2005.11.013
10.1039/D2CS00494A
10.1021/cr100346g
10.1056/NEJMcp0803572
10.1039/c2md20347b
10.1021/jm501100b
10.1021/jacs.6b00250
10.1021/acs.accounts.5b00057
10.1007/s40261-018-0656-y
10.1897/01-198
10.1038/nature13274
10.1021/acs.orglett.1c02101
10.1016/j.drudis.2019.10.014
10.1021/acs.jmedchem.0c01786
10.1021/acsmedchemlett.3c00118
10.1021/acs.accounts.0c00291
10.1055/s-0036-1591853
10.1093/toxsci/56.1.8
10.1016/S0169-409X(96)00423-1
10.1021/ol0272693
10.1021/acs.chemrev.1c00383
10.1021/acsmedchemlett.0c00292
10.1038/s41929-023-00925-4
10.1021/acs.jmedchem.2c01646
10.1002/chem.201402302
10.1021/acs.accounts.1c00480
10.31635/ccschem.021.202101196
10.4155/fmc-2016-0095
10.1093/oso/9780198501213.003.0006
10.1021/acs.organomet.8b00720
10.1021/acsmedchemlett.0c00093
10.3390/molecules24213839
10.1021/jacs.6b00016
10.1038/s41563-021-01156-3
10.1002/chem.200901913
10.1016/j.chempr.2020.04.005
10.1016/j.drudis.2020.09.009
10.1021/ol702499h
10.1021/acs.jmedchem.0c00829
10.1021/acs.orglett.2c04226
10.1002/chem.201402509
10.1021/jm200504p
10.1016/j.trechm.2019.08.004
10.1016/j.trechm.2021.02.005
10.1021/jm901241e
10.1021/ml500463t
10.1002/anie.201901866
10.1002/ijch.201900072
10.1039/b805648j
10.1021/jacs.5b04725
ContentType Journal Article
Copyright 2024 American Chemical Society
Copyright_xml – notice: 2024 American Chemical Society
DBID NPM
AAYXX
CITATION
7X8
DOI 10.1021/jacs.4c08404
DatabaseName PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle PubMed
CrossRef
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
PubMed
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
EISSN 1520-5126
EndPage 21270
ExternalDocumentID 10_1021_jacs_4c08404
39052124
c570111915
Genre Journal Article
GroupedDBID ---
-DZ
-ET
-~X
.DC
.K2
4.4
53G
55A
5GY
5RE
5VS
7~N
85S
AABXI
AAHBH
ABFRP
ABJNI
ABMVS
ABPPZ
ABQRX
ABUCX
ACBEA
ACGFO
ACGFS
ACJ
ACNCT
ACS
ADHLV
AEESW
AENEX
AFEFF
AGXLV
AHGAQ
ALMA_UNASSIGNED_HOLDINGS
AQSVZ
BAANH
BKOMP
CS3
CUPRZ
DU5
EBS
ED~
F5P
GGK
GNL
IH2
IH9
JG~
LG6
P2P
ROL
RXW
TAE
TN5
UHB
UI2
UKR
UPT
VF5
VG9
VQA
W1F
WH7
XSW
YQT
YZZ
ZCA
~02
NPM
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-a211t-56a971835d8fc9f4b55fa686a9ff102e7c305ca9cd9fea84c6888c52f37437f23
IEDL.DBID ACS
ISSN 0002-7863
1520-5126
IngestDate Sat Oct 26 04:32:31 EDT 2024
Wed Aug 14 12:30:39 EDT 2024
Sat Nov 02 12:26:03 EDT 2024
Thu Aug 08 06:03:17 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 31
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-a211t-56a971835d8fc9f4b55fa686a9ff102e7c305ca9cd9fea84c6888c52f37437f23
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-2543-0221
0000-0003-0243-0357
0000-0003-3034-9097
0000-0002-8700-4615
PMID 39052124
PQID 3084772482
PQPubID 23479
PageCount 7
ParticipantIDs proquest_miscellaneous_3084772482
crossref_primary_10_1021_jacs_4c08404
pubmed_primary_39052124
acs_journals_10_1021_jacs_4c08404
PublicationCentury 2000
PublicationDate 2024-Aug-07
PublicationDateYYYYMMDD 2024-08-07
PublicationDate_xml – month: 08
  year: 2024
  text: 2024-Aug-07
  day: 07
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Journal of the American Chemical Society
PublicationTitleAlternate J. Am. Chem. Soc
PublicationYear 2024
Publisher American Chemical Society
Publisher_xml – name: American Chemical Society
References ref2/cit2f
ref2/cit2e
ref2/cit2d
ref13/cit13a
ref13/cit13b
ref13/cit13c
ref13/cit13d
ref13/cit13e
ref12/cit12c
ref13/cit13f
ref12/cit12b
ref13/cit13g
ref12/cit12a
ref13/cit13h
ref2/cit2c
ref2/cit2b
ref2/cit2a
ref1/cit1a
ref1/cit1b
ref5/cit5b
ref17/cit17
ref5/cit5c
ref5/cit5a
ref16/cit16c
ref16/cit16b
ref16/cit16a
ref21/cit21
ref7/cit7e
ref16/cit16e
ref7/cit7d
ref16/cit16d
ref3/cit3b
ref11/cit11c
ref22/cit22a
ref11/cit11b
ref3/cit3a
ref22/cit22e
ref22/cit22d
ref11/cit11a
ref22/cit22c
ref22/cit22b
ref7/cit7c
ref7/cit7b
ref22/cit22h
ref7/cit7a
ref22/cit22g
ref22/cit22f
ref19/cit19a
ref18/cit18
ref19/cit19c
ref19/cit19b
ref9/cit9c
ref10/cit10d
ref9/cit9b
ref9/cit9a
ref25/cit25
ref8/cit8a
ref10/cit10a
ref10/cit10b
ref8/cit8b
ref10/cit10c
ref9/cit9h
ref9/cit9g
ref9/cit9f
ref9/cit9e
ref9/cit9d
Diederich F. (ref6/cit6) 2004
ref4/cit4a
ref4/cit4b
ref4/cit4c
ref20/cit20a
ref20/cit20c
ref20/cit20b
ref20/cit20d
ref4/cit4d
ref4/cit4e
ref4/cit4f
ref4/cit4g
ref4/cit4h
ref4/cit4i
ref4/cit4j
References_xml – ident: ref11/cit11a
  doi: 10.1246/bcsj.53.139
– ident: ref13/cit13h
  doi: 10.1002/anie.201802656
– ident: ref21/cit21
  doi: 10.1126/science.1178165
– ident: ref20/cit20a
  doi: 10.1021/ja00234a047
– ident: ref22/cit22b
  doi: 10.1021/jo500507s
– ident: ref16/cit16a
  doi: 10.1556/JFC-D-13-00009
– ident: ref20/cit20d
  doi: 10.1002/anie.201605463
– ident: ref20/cit20c
  doi: 10.1021/jacs.6b01533
– ident: ref9/cit9f
  doi: 10.1002/cctc.202201289
– ident: ref11/cit11b
  doi: 10.1016/0277-5387(95)00141-E
– ident: ref4/cit4b
  doi: 10.1021/acscatal.5b00072
– ident: ref9/cit9g
  doi: 10.1016/j.trechm.2023.10.008
– ident: ref11/cit11c
  doi: 10.1021/acscatal.8b00856
– ident: ref9/cit9h
  doi: 10.1021/acs.orglett.3c01390
– ident: ref4/cit4c
  doi: 10.1038/s41570-017-0025
– ident: ref10/cit10a
  doi: 10.1073/pnas.93.21.11865
– ident: ref16/cit16c
  doi: 10.1021/acs.joc.8b02358
– ident: ref13/cit13b
  doi: 10.1016/S0040-4020(00)00344-6
– ident: ref4/cit4g
  doi: 10.1021/acs.accounts.0c00032
– ident: ref12/cit12c
  doi: 10.1021/acscatal.5b02718
– ident: ref9/cit9a
  doi: 10.1038/nrd.2017.232
– ident: ref10/cit10d
  doi: 10.1038/s41598-019-52085-w
– ident: ref16/cit16b
  doi: 10.1002/adsc.201400243
– ident: ref25/cit25
  doi: 10.1038/s41557-024-01528-7
– ident: ref13/cit13a
  doi: 10.1021/ja982520o
– ident: ref18/cit18
  doi: 10.1021/acs.jmedchem.1c01139
– ident: ref4/cit4h
  doi: 10.1039/C9SC06006E
– ident: ref22/cit22a
  doi: 10.1021/ja301769r
– ident: ref8/cit8a
  doi: 10.1126/science.aac6153
– ident: ref17/cit17
  doi: 10.1016/j.trechm.2023.03.008
– ident: ref13/cit13d
  doi: 10.1016/j.tetlet.2005.11.013
– ident: ref7/cit7e
  doi: 10.1039/D2CS00494A
– ident: ref1/cit1a
  doi: 10.1021/cr100346g
– ident: ref10/cit10b
  doi: 10.1056/NEJMcp0803572
– ident: ref2/cit2d
  doi: 10.1039/c2md20347b
– ident: ref5/cit5a
  doi: 10.1021/jm501100b
– ident: ref20/cit20b
  doi: 10.1021/jacs.6b00250
– ident: ref22/cit22e
  doi: 10.1021/acs.accounts.5b00057
– ident: ref10/cit10c
  doi: 10.1007/s40261-018-0656-y
– ident: ref3/cit3b
  doi: 10.1897/01-198
– ident: ref4/cit4a
  doi: 10.1038/nature13274
– ident: ref8/cit8b
  doi: 10.1021/acs.orglett.1c02101
– ident: ref1/cit1b
  doi: 10.1016/j.drudis.2019.10.014
– ident: ref5/cit5c
  doi: 10.1021/acs.jmedchem.0c01786
– volume-title: Metal-Catalyzed Cross-Coupling Reactions
  year: 2004
  ident: ref6/cit6
  contributor:
    fullname: Diederich F.
– ident: ref19/cit19c
  doi: 10.1021/acsmedchemlett.3c00118
– ident: ref22/cit22g
  doi: 10.1021/acs.accounts.0c00291
– ident: ref22/cit22f
  doi: 10.1055/s-0036-1591853
– ident: ref3/cit3a
  doi: 10.1093/toxsci/56.1.8
– ident: ref2/cit2a
  doi: 10.1016/S0169-409X(96)00423-1
– ident: ref13/cit13c
  doi: 10.1021/ol0272693
– ident: ref4/cit4j
  doi: 10.1021/acs.chemrev.1c00383
– ident: ref9/cit9b
  doi: 10.1021/acsmedchemlett.0c00292
– ident: ref7/cit7d
  doi: 10.1038/s41929-023-00925-4
– ident: ref16/cit16d
  doi: 10.1021/acs.jmedchem.2c01646
– ident: ref22/cit22d
  doi: 10.1002/chem.201402302
– ident: ref22/cit22h
  doi: 10.1021/acs.accounts.1c00480
– ident: ref4/cit4i
  doi: 10.31635/ccschem.021.202101196
– ident: ref2/cit2e
  doi: 10.4155/fmc-2016-0095
– ident: ref12/cit12a
  doi: 10.1093/oso/9780198501213.003.0006
– ident: ref4/cit4e
  doi: 10.1021/acs.organomet.8b00720
– ident: ref19/cit19b
  doi: 10.1021/acsmedchemlett.0c00093
– ident: ref5/cit5b
  doi: 10.3390/molecules24213839
– ident: ref7/cit7a
  doi: 10.1021/jacs.6b00016
– ident: ref9/cit9e
  doi: 10.1038/s41563-021-01156-3
– ident: ref13/cit13f
  doi: 10.1002/chem.200901913
– ident: ref4/cit4f
  doi: 10.1016/j.chempr.2020.04.005
– ident: ref9/cit9c
  doi: 10.1016/j.drudis.2020.09.009
– ident: ref13/cit13e
  doi: 10.1021/ol702499h
– ident: ref2/cit2f
  doi: 10.1021/acs.jmedchem.0c00829
– ident: ref16/cit16e
  doi: 10.1021/acs.orglett.2c04226
– ident: ref22/cit22c
  doi: 10.1002/chem.201402509
– ident: ref2/cit2c
  doi: 10.1021/jm200504p
– ident: ref7/cit7b
  doi: 10.1016/j.trechm.2019.08.004
– ident: ref9/cit9d
  doi: 10.1016/j.trechm.2021.02.005
– ident: ref2/cit2b
  doi: 10.1021/jm901241e
– ident: ref19/cit19a
  doi: 10.1021/ml500463t
– ident: ref7/cit7c
  doi: 10.1002/anie.201901866
– ident: ref4/cit4d
  doi: 10.1002/ijch.201900072
– ident: ref12/cit12b
  doi: 10.1039/b805648j
– ident: ref13/cit13g
  doi: 10.1021/jacs.5b04725
SSID ssj0004281
Score 2.5039766
Snippet Herein, we describe nickel oxidative addition complexes (Ni-OACs) of drug-like molecules as a platform to rapidly generate lead candidates with enhanced C­(sp...
Herein, we describe nickel oxidative addition complexes (Ni-OACs) of drug-like molecules as a platform to rapidly generate lead candidates with enhanced C( )...
Herein, we describe nickel oxidative addition complexes (Ni-OACs) of drug-like molecules as a platform to rapidly generate lead candidates with enhanced C(sp3)...
SourceID proquest
crossref
pubmed
acs
SourceType Aggregation Database
Index Database
Publisher
StartPage 21264
Title Late-Stage C(sp 2)–C(sp 3) Diversification via Nickel Oxidative Addition Complexes
URI http://dx.doi.org/10.1021/jacs.4c08404
https://www.ncbi.nlm.nih.gov/pubmed/39052124
https://www.proquest.com/docview/3084772482
Volume 146
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1LS8NAEF60HvTi-1FfbEHFHiLtZl85lrSlB9FDK3gL231IsaTFtNKj_8F_6C9x8lIUCr2FzYNhZpL5vszsDEJX0hrDSZN6rskkEBTme0MKLMUKxoUzzuSzAXt98fAs2520Tc7Nkgw-SfsD6eSO6gYwEbqONogAkJBCoLD_u_-RyGYJc4XkflHg_v_uNADp5G8AWoIqs-jS3VlVrl20XeBH3MoNvofWbLyPNsNybNsBGtwDevQAQ75YHN4mU0zqXx-f2ZFfx-28DMMVf-rw-0hhcIZXO8aPi5HJuoDjljFZIRdOPxZju7DJIXrqdgZhzytGJ3gKGN3MY1wFEHV8ZqTTgaNDxpziEladA-mt0PCeaxVoEzirJNUcmLBmxPmAKIQj_hGqxJPYniCslZQu7SPIAkqFosrZBhU2MIprzqmuohpoIipcP4myrDYBVpGuFvqpoutS59E076Kx5LpaaZAI1JbmLlRsJ_Mk8uE8EAEqSRUd55b6eZIfZDuQ6ekKkpyhLQKwJCvhE-eoMnub2wu0npj5ZeZT31XAwyg
link.rule.ids 315,782,786,2769,27085,27933,27934,56747,56797
linkProvider American Chemical Society
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LS8NAEB58HPTi-1GfW1DQQ6BN9pVjqZaKVQ-t4C1s9yHF0hZjxaP_wX_oL3GySRQFQW9hkgzD7G7m-zKzswBH0hrDwzoNXJ1JJCgsCvoUWYoVjAtnnMnPBmx3xfWdPDvP2uQE5V4YNCJFTalP4n91F8jaBKGQ6hoSEjoL86iJZlyr0ex-bYMMZb1Eu0LyqKhz__l2Fod0-j0O_QIufZBpLf_TvBVYKtAkaeTDvwozdrQGC83yELd16HUQSwaIKO8taZ6kExKevr---avolJzlRRmu-G9HngeK4NR4sENy8zIwvic4aRjjy7pI9ukY2hebbsBt67zXbAfFQQqBQn73FDCuYoxBETPS6djRPmNOcYlS59B6KzSueq1ibWJnlaSaIy_WLHQR4gvhwmgT5kbjkd0GopWULusqyGJKhaLK2RoVNjaKa86prkAVPZEUCyFNfI47RI6RSQv_VOC4dH0yyXtq_PJctRyXBN2WZTLUyI6naRLhfaQFVIYV2MoH7FNTFPv9yHTnD5YcwkK7d9VJOhfXl7uwGCJg8cV9Yg_mnh6ndh9mUzM98NPsA_Wjy5U
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ZS8QwEB48QH3xPtYzCwr6UHDbXH1cdl0URYVV8K3EHCIuu4t1xUf_g__QX-IkbRUFQXwrSRuGyUzn-5LJBGBXWmN43KCRazCJBIUl0S1FlmIF48IZZ4q7AY-74vxGto98mZxGdRYGhchxpDxs4nuvHhpXVhjwpYKwg-pDJCV0HCZxtNTzrWar-3UUMpaNCvEKyZMy1_3n1z4W6fx7LPoFYIZA05n7h4jzMFuiStIszGABxmx_EaZb1WVuS3B1hpgyQmR5Z0lrPx-S-OD99S08JQekXSRnuHL9jjzfK4Im8mB75OLl3oTa4KRpTEjvIv4X0rMvNl-G687RVes4Ki9UiBTyvKeIcZViLEqYkU6njt4y5hSX2OocSm-FRu_XKtUmdVZJqjnyY81ilyDOEC5OVmCiP-jbNSBaSel8dUGWUioUVc4eUmFTo7jmnOoa1FETWekQeRb2umPkGr611E8N9ir1Z8OitsYv79WruclQbX5HQ_XtYJRnCfYjPaAyrsFqMWmfIyVpOJdM1_8gyQ5MXbY72dnJ-ekGzMSIW0KOn9iEiafHkd2C8dyMtoOlfQDTiM4Y
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Late-Stage+C%28sp2%29-C%28sp3%29+Diversification+via+Nickel+Oxidative+Addition+Complexes&rft.jtitle=Journal+of+the+American+Chemical+Society&rft.au=Odena%2C+Carlota&rft.au=Santiago%2C+Tom%C3%A1s+G&rft.au=Linares%2C+Mar%C3%ADa+Lourdes&rft.au=Castellanos-Blanco%2C+Nahury&rft.date=2024-08-07&rft.issn=1520-5126&rft.eissn=1520-5126&rft.volume=146&rft.issue=31&rft.spage=21264&rft_id=info:doi/10.1021%2Fjacs.4c08404&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0002-7863&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0002-7863&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0002-7863&client=summon